West Pharmaceutical Services

-7.02%

Live  

West Pharmaceutical Services is a leading global provider of innovative solutions for injectable drug administration. The company was founded in 1923 in Philadelphia, Pennsylvania and has since expanded to have a global presence with operations in North and South America, Europe, Asia, and Australia.
The company specializes in developing and manufacturing packaging, delivery systems, and diagnostic products for injectable drugs. This includes items such as syringe and cartridge components, closure systems, and self-injection systems. They also offer contract manufacturing services for pharmaceutical and biotechnology companies.
West Pharmaceutical Services is committed to providing high-quality, safe, and effective solutions for drug administration. Their products are used in a wide range of therapeutic areas including oncology, immunology, and diabetes.
In addition to their focus on product development and manufacturing, West Pharmaceutical Services also places a strong emphasis on sustainability and has implemented environmentally-friendly practices in their operations and product designs.
The company has a diverse workforce of over 9,500 employees and is dedicated to creating a positive and inclusive work environment. They also prioritize giving back to the community through their philanthropic efforts and involvement in various charitable initiatives.
Overall, West Pharmaceutical Services is a trusted partner for pharmaceutical and biotech companies, offering innovative solutions and a commitment to improving the global healthcare landscape.

West Pharmaceutical Services is a company that helps make sure medicines and vaccines are safe and easy to use. You know how when you go to the doctor, they sometimes give you a shot or a pill? Well, West makes special containers, like syringes and vials, that hold these medicines. They also create the things that keep the medicines safe inside those containers, like seals and caps.
West makes money by selling these containers and parts to big companies that make drugs and vaccines. When these companies need something to hold their medicine, or a way to deliver it easily and safely to patients, they buy West’s products.
West is successful for a few reasons. First, they have been around for a long time, so they know a lot about how to make these products really well. They work with many important companies, which helps them get steady business. Second, there are always new medicines and vaccines being developed, especially when people want to solve health problems. This means that West will keep having customers.
Looking ahead, West is likely to stay successful because:
1. Health is very important to everyone, and new medicines are being discovered all the time. This means West will always be needed.
2. They focus on making high-quality products, and when people trust a company, they usually keep coming back.
3. They’re also investing in new technology to make even better products, and this can help them attract more customers in the future.
So, West Pharmaceutical Services helps keep our medicines safe and easy to use, and they have a good plan for continuing their success!

MS4gRGl2ZX JzZSBQcm9k dWN0IFBvcn Rmb2xpbzog V2VzdCBQaG FybWFjZXV0 aWNhbCBTZX J2aWNlcyBo YXMgYSBkaX ZlcnNlIHBy b2R1Y3QgcG 9ydGZvbGlv LCBvZmZlcm luZyBhIHdp ZGUgcmFuZ2 Ugb2YgcGFj a2FnaW5nIG NvbXBvbmVu dHMgYW5kIG RlbGl2ZXJ5 IHN5c3RlbX MgZm9yIGlu amVjdGFibG UgZHJ1Z3Ms IGJpb2xvZ2 ljcywgYW5k IHZhY2Npbm VzLiBUaGlz IGVuYWJsZX MgdGhlIGNv bXBhbnkgdG 8gc2VydmUg YSB3aWRlIH ZhcmlldHkg b2YgY3VzdG 9tZXJzIGlu IHRoZSBwaG FybWFjZXV0 aWNhbCBhbm QgYmlvdGVj aG5vbG9neS BpbmR1c3Ry aWVzLjxicj 4yLiBFeHBl cnRpc2UgaW 4gRHJ1ZyBE ZWxpdmVyeS BTeXN0ZW1z OiBXZXN0IF BoYXJtYWNl dXRpY2FsIF NlcnZpY2Vz IGhhcyBhIH N0cm9uZyBl eHBlcnRpc2 UgaW4gZGV2 ZWxvcGluZy BhbmQgbWFu dWZhY3R1cm luZyBkcnVn IGRlbGl2ZX J5IHN5c3Rl bXMsIGluY2 x1ZGluZyBz eXJpbmdlIH N5c3RlbXMs IGF1dG8taW 5qZWN0b3Jz LCBhbmQgd2 VhcmFibGUg aW5qZWN0b3 IgZGV2aWNl cy4gVGhpcy BoYXMgaGVs cGVkIHRoZS Bjb21wYW55 IHRvIGJlY2 9tZSBhIHRy dXN0ZWQgcG FydG5lciBm b3IgcGhhcm 1hY2V1dGlj YWwgY29tcG FuaWVzIGxv b2tpbmcgZm 9yIGFkdmFu Y2VkIGFuZC Bpbm5vdmF0 aXZlIHNvbH V0aW9ucyBm b3IgZHJ1Zy BkZWxpdmVy eS48YnI+My 4gR2xvYmFs IFJlYWNoOi BXaXRoIG9w ZXJhdGlvbn MgaW4gb3Zl ciA1MCBjb3 VudHJpZXMs IFdlc3QgUG hhcm1hY2V1 dGljYWwgU2 VydmljZXMg aGFzIGEgZ2 xvYmFsIHJl YWNoIGFuZC BpcyB3ZWxs IHBvc2l0aW 9uZWQgdG8g c2VydmUgY3 VzdG9tZXJz IHdvcmxkd2 lkZS4gVGhp cyBhbHNvIH Byb3ZpZGVz IHRoZSBjb2 1wYW55IHdp dGggYSBkaX ZlcnNpZmll ZCByZXZlbn VlIHN0cmVh bSwgcmVkdW NpbmcgaXRz IGRlcGVuZG VuY2Ugb24g YW55IHNpbm dsZSBtYXJr ZXQuPGJyPj QuIENvbW1p dG1lbnQgdG 8gUXVhbGl0 eSBhbmQgSW 5ub3ZhdGlv bjogV2VzdC BQaGFybWFj ZXV0aWNhbC BTZXJ2aWNl cyBpcyBjb2 1taXR0ZWQg dG8gZGVsaX ZlcmluZyBo aWdoLXF1YW xpdHkgcHJv ZHVjdHMgYW 5kIHNlcnZp Y2VzIHRvIG l0cyBjdXN0 b21lcnMuIF RoZSBjb21w YW55IGludm VzdHMgaGVh dmlseSBpbi ByZXNlYXJj aCBhbmQgZG V2ZWxvcG1l bnQsIHdpdG ggYSBmb2N1 cyBvbiBpbm 5vdmF0aXZl IHNvbHV0aW 9ucyB0aGF0 IGltcHJvdm UgdGhlIHNh ZmV0eSBhbm QgZWZmaWNh Y3kgb2YgZH J1ZyBkZWxp dmVyeS48Yn I+NS4gU3Ry b25nIEN1c3 RvbWVyIFJl bGF0aW9uc2 hpcHM6IFRo cm91Z2ggaX RzIGRlZGlj YXRpb24gdG 8gY3VzdG9t ZXIgc2Vydm ljZSBhbmQg Y29sbGFib3 JhdGl2ZSBh cHByb2FjaC wgV2VzdCBQ aGFybWFjZX V0aWNhbCBT ZXJ2aWNlcy BoYXMgYnVp bHQgbG9uZy 10ZXJtIHJl bGF0aW9uc2 hpcHMgd2l0 aCBpdHMgY3 VzdG9tZXJz LiBUaGUgY2 9tcGFueSB3 b3JrcyBjbG 9zZWx5IHdp dGggaXRzIG NsaWVudHMg dG8gdW5kZX JzdGFuZCB0 aGVpciBuZW VkcyBhbmQg ZGV2ZWxvcC BjdXN0b21p emVkIHNvbH V0aW9ucyBm b3IgdGhlaX Igc3BlY2lm aWMgcHJvZH VjdHMuPGJy PjYuIFN1c3 RhaW5hYmxl IGFuZCBTb2 NpYWxseSBS ZXNwb25zaW JsZSBQcmFj dGljZXM6IF dlc3QgUGhh cm1hY2V1dG ljYWwgU2Vy dmljZXMgaX MgY29tbWl0 dGVkIHRvIH N1c3RhaW5h YmlsaXR5IG FuZCBoYXMg aW1wbGVtZW 50ZWQgdmFy aW91cyBpbm l0aWF0aXZl cyB0byByZW R1Y2UgaXRz IGVudmlyb2 5tZW50YWwg aW1wYWN0Li BUaGUgY29t cGFueSBhbH NvIHZhbHVl cyBjb3Jwb3 JhdGUgc29j aWFsIHJlc3 BvbnNpYmls aXR5LCBhY3 RpdmVseSBz dXBwb3J0aW 5nIGNvbW11 bml0aWVzIH Rocm91Z2gg dmFyaW91cy BwaGlsYW50 aHJvcGljIG VmZm9ydHMu PGJyPjcuIF N0cm9uZyBG aW5hbmNpYW wgUGVyZm9y bWFuY2U6IF dlc3QgUGhh cm1hY2V1dG ljYWwgU2Vy dmljZXMgaG FzIGEgc3Ry b25nIGZpbm FuY2lhbCBw ZXJmb3JtYW 5jZSwgd2l0 aCBjb25zaX N0ZW50IHJl dmVudWUgZ3 Jvd3RoIGFu ZCBwcm9maX RhYmlsaXR5 LiBUaGlzIG hhcyBlbmFi bGVkIHRoZS Bjb21wYW55 IHRvIGludm VzdCBpbiBp bm5vdmF0aW 9uIGFuZCBl eHBhbmQgaX RzIGdsb2Jh bCBwcmVzZW 5jZSB0aHJv dWdoIHN0cm F0ZWdpYyBh Y3F1aXNpdG lvbnMgYW5k IHBhcnRuZX JzaGlwcy4=

VGhlIFdlc3 QgUGhhcm1h Y2V1dGljYW wgU2Vydmlj ZXMgY29tcG FueSBpcyBh IGxlYWRpbm cgZ2xvYmFs IHByb3ZpZG VyIG9mIGlu bm92YXRpdm Ugc29sdXRp b25zIGZvci BpbmplY3Rh YmxlIGRydW cgYWRtaW5p c3RyYXRpb2 4gYW5kIGRl bGl2ZXJ5Li BUaGVpciBi dXNpbmVzcy Btb2RlbCBp cyBmb2N1c2 VkIG9uIG1h bnVmYWN0dX JpbmcgYW5k IHN1cHBseW luZyBwYWNr YWdpbmcsIG RlbGl2ZXJ5 LCBhbmQgYW RtaW5pc3Ry YXRpb24gc3 lzdGVtcyBm b3IgaW5qZW N0YWJsZSBt ZWRpY2luZX MsIGFsb25n IHdpdGggb2 ZmZXJpbmcg cmVsYXRlZC BzZXJ2aWNl cyBzdWNoIG FzIGNvbnRy YWN0IG1hbn VmYWN0dXJp bmcsIGRldm Vsb3BtZW50 IGFuZCB0ZX N0aW5nLCBh bmQgdGVjaG 5pY2FsIHN1 cHBvcnQuPG JyPlRoZXkg d29yayB3aX RoIHBoYXJt YWNldXRpY2 FsIGFuZCBi aW90ZWNobm 9sb2d5IGNv bXBhbmllcy B0byBkZXZl bG9wIGN1c3 RvbWl6ZWQg c29sdXRpb2 5zIHRoYXQg bWVldCB0aG VpciBzcGVj aWZpYyBkcn VnIGRlbGl2 ZXJ5IG5lZW RzLiBUaGlz IGluY2x1ZG VzIGRldmVs b3BpbmcgYW 5kIG1hbnVm YWN0dXJpbm cgdmlhbCBh bmQgc3lyaW 5nZSBzeXN0 ZW1zLCBzdG 9wcGVycywg YW5kIG90aG VyIGNvbXBv bmVudHMgZm 9yIGRydWcg cGFja2FnaW 5nLCBhcyB3 ZWxsIGFzIH NhZmV0eSBz eXN0ZW1zIG ZvciB0aGUg c2FmZSBhZG 1pbmlzdHJh dGlvbiBvZi BpbmplY3Rh YmxlIG1lZG ljaW5lcy48 YnI+V2VzdC BhbHNvIG9m ZmVycyBzZX J2aWNlcyBz dWNoIGFzIG NvbnRyYWN0 IG1hbnVmYW N0dXJpbmcg YW5kIGRldm ljZSBhc3Nl bWJseSwgd2 hlcmUgdGhl eSBwcm9kdW NlIGFuZCBh c3NlbWJsZS BwaGFybWFj ZXV0aWNhbC BwYWNrYWdp bmcgY29tcG 9uZW50cyBm b3IgdGhlaX IgY2xpZW50 cywgYW5kIG NvbnRyYWN0 IHBhY2thZ2 luZywgd2hl cmUgdGhleS Bwcm92aWRl IHBhY2thZ2 luZyBhbmQg bGFiZWxpbm cgc2Vydmlj ZXMgZm9yIH RoZWlyIGNs aWVudHMnIH Byb2R1Y3Rz Ljxicj5UaG VpciBidXNp bmVzcyBtb2 RlbCBpcyBi dWlsdCBvbi BhIGZvdW5k YXRpb24gb2 YgaW5ub3Zh dGlvbiBhbm QgY3VzdG9t ZXIgY29sbG Fib3JhdGlv biwgd2hlcm UgdGhleSB3 b3JrIGNsb3 NlbHkgd2l0 aCB0aGVpci BjbGllbnRz IHRvIGRldm Vsb3AgdGFp bG9yZWQgc2 9sdXRpb25z IHRoYXQgbW VldCB0aGVp ciB1bmlxdW UgcmVxdWly ZW1lbnRzLi BUaGlzIGFw cHJvYWNoIG hhcyBoZWxw ZWQgV2VzdC BiZWNvbWUg YSB0cnVzdG VkIHBhcnRu ZXIgZm9yIH BoYXJtYWNl dXRpY2FsIG FuZCBiaW90 ZWNobm9sb2 d5IGNvbXBh bmllcyB3b3 JsZHdpZGUs IHdpdGggYS BzdHJvbmcg Zm9jdXMgb2 4gcXVhbGl0 eSwgc2FmZX R5LCBhbmQg Y29tcGxpYW 5jZS4=

AI may pose certain challenges to West Pharmaceutical Services in several ways, but its overall impact will depend on how the company adapts and integrates these technologies into its operations.
1. Substitution: AI could enable new technologies or products that might substitute for traditional pharmaceutical delivery methods. For instance, advancements in digital health solutions and automated drug delivery systems could change how medications are administered, potentially affecting West’s existing product lines. However, West has a strong focus on innovation, which could provide opportunities to adapt its offerings to incorporate AI advancements instead of replacing them.
2. Disintermediation: The rise of self-administration and remote monitoring technologies could lead to disintermediation in the pharmaceutical supply chain. If patients increasingly manage their own drug delivery and monitoring through AI-powered devices, this could reduce demand for certain products that West offers. However, West could mitigate this risk by expanding its portfolio to include technologies that support home care and patient-centered solutions.
3. Margin Pressure: As AI-driven advancements create efficiencies in manufacturing and distribution, competitors might leverage these innovations to reduce costs or improve product quality. This could pressure West’s profit margins if it doesn’t keep pace with these developments. To counteract potential margin compression, West would need to invest in AI and automation in its own operations to improve efficiency and maintain competitiveness.
Overall, while AI presents certain risks to West Pharmaceutical Services, it also offers opportunities for growth and enhancement of its product and service offerings. The key will be how effectively the company can adapt to and leverage these technological changes.

The sensitivity of West Pharmaceutical Services’ earnings, cash flow, and valuation to changes in interest rates can be analyzed through several key factors:
1. Cost of Capital: Higher interest rates increase the cost of borrowing. For West Pharmaceutical, which may rely on debt to finance operations or expand its business, increased interest expenses can reduce net earnings. If the company has a significant amount of variable-rate debt, its cash flow might also be directly impacted as interest payments rise.
2. Discount Rate in Valuation: Valuation models, particularly discounted cash flow (DCF) analyses, use an estimated discount rate to calculate present value. An increase in interest rates typically raises the discount rate, leading to a lower present value of future cash flows. This can result in a decreased valuation of the company.
3. Impact on Investments: Higher interest rates may deter capital investments by the company, as the return on investments needs to exceed these higher rates to justify spending. This can lead to slower growth in revenues and cash flows in the long term.
4. Market Demand and Sales: Rising interest rates can impact overall economic conditions, potentially affecting demand for the healthcare products that West Pharmaceutical provides. If consumers and hospitals face higher financing costs, it might influence their purchasing decisions, ultimately affecting revenues.
5. Cash Flow Management: Changes in interest rates can also affect working capital management. For example, if rates rise and the company has to pay more interest on short-term borrowings, it may tighten cash flow availability for operations and other investments.
6. Sensitivity Analysis: Although exact sensitivities can vary, companies like West Pharmaceutical typically analyze their earnings and cash flow sensitivity to interest rate changes through scenario planning. A 1% increase in interest rates can be used as a benchmark to estimate the potential impact on earnings and cash flows.
In summary, West Pharmaceutical Services’ earnings, cash flow, and valuation can be negatively impacted by rising interest rates due to increased borrowing costs, higher discount rates in valuations, constraints on investments, and possible reductions in demand for its products. The overall sensitivity would depend on the company’s capital structure, operational efficiency, and market position.

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvVz BEcm5JU2Fi Sks5WHlxVW ROYXAud2Vi cCIgYWx0PS JXZXN0IFBo YXJtYWNldX RpY2FsIFNl cnZpY2VzIi B0aXRsZT0i V2VzdCBQaG FybWFjZXV0 aWNhbCBTZX J2aWNlcyIg IGNsYXNzPS JpbWctZmx1 aWQiIGhlaW dodD05MCB3 aWR0aD05MC Bsb2FkaW5n PSdsYXp5Jy BzdHlsZT0n Ym9yZGVyLX JhZGl1czog NnB4Oyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxk aXYgc3R5bG U9J2ZsZXg6 IDE7IHRleH QtYWxpZ246 IGNlbnRlcj sgbWFyZ2lu LWxlZnQ6ID VweDsnPgog ICAgICAgIC AgICAgICAg ICAgICAgIC A8cCBzdHls ZT0nZm9udC 1zaXplOiAy NnB4OyBjb2 xvcjogIzMz MzsgbWFyZ2 luLWJvdHRv bTogMTVweD snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Ag8J+TiCBX YW50IHRvIH JlYWQgbW9y ZSBhYm91dC BXZXN0IFBo YXJtYWNldX RpY2FsIFNl cnZpY2VzPw ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L3A+Cg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8YSBocm VmPSdpbmRl eC5waHA/cG FnZT1zaWdu dXAnIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICMw MDdCRkY7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBjb2 xvcjogI2Zm ZjsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IHBhZGRpbm c6IDEwcHgg MjBweDsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIGJvcm Rlci1yYWRp dXM6IDVweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIH RleHQtZGVj b3JhdGlvbj ogbm9uZTsK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGZv bnQtd2VpZ2 h0OiBib2xk OwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luLX JpZ2h0OiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgdHJhbn NpdGlvbjog YmFja2dyb3 VuZC1jb2xv ciAwLjNzIG Vhc2U7Jwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgb25t b3VzZW92ZX I9J3RoaXMu c3R5bGUuYm Fja2dyb3Vu ZENvbG9yPS IjMDA1NmIz IicKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IG9ubW91c2 VvdXQ9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA3 QkZGIic+Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBTaW duIHVwIGZv ciBmcmVlCi AgICAgICAg ICAgICAgIC AgICAgICAg IDwvYT4KCi AgICAgICAg ICAgICAgIC AgICAgICAg IDxzcGFuIH N0eWxlPSdt YXJnaW46ID AgOHB4OyBj b2xvcjogIz U1NTsnPm9y PC9zcGFuPg oKICAgICAg ICAgICAgIC AgICAgICAg ICAgPGEgaH JlZj0naW5k ZXgucGhwP3 BhZ2U9bG9n aW4nIHN0eW xlPScKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIGNvbG9y OiAjMDA3Qk ZGOwogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgdGV4dC1k ZWNvcmF0aW 9uOiB1bmRl cmxpbmU7Ci AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICBmb2 50LXdlaWdo dDogNTAwOy c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bsb2cgaW4K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPC9hPgoK CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdtYX JnaW4tdG9w OiAxNXB4Oy Bmb250LXNp emU6IDEzcH g7IGZvbnQt d2VpZ2h0Oi Bib2xkOyBj b2xvcjogI2 QzMmYyZjsn PgogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg 8J+SoSBMZW FybiBzbWFy dGVyIHN0b2 NrIHBpY2tz IHdpdGggPG k+IlRoZSBD aGVja2xpc3 QgVmFsdWUg SW52ZXN0b3 Ig4oCUIEEg U21hcnRlci BXYXkgdG8g UGljayBTdG 9ja3MiPC9p PgogICAgIC AgICAgICAg ICAgICAgIC AgICA8L3A+ CgogICAgIC AgICAgICAg ICAgICAgIC AgICA8IS0t CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxkaXYg c3R5bGU9J2 1hcmdpbi10 b3A6IDEycH g7IGZvbnQt c2l6ZTogMT NweDsgY29s b3I6ICM0ND Q7Jz4KICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIFNpZ24g dXAgbm93IG FuZCBnZXQg b3VyIGZyZW UgZUJvb2sg CiAgICAgIC AgICAgICAg ICAgICAgIC AgICAgICA8 Yj5UaGUgQ2 hlY2tsaXN0 IFZhbHVlIE ludmVzdG9y IOKAlCBBIF NtYXJ0ZXIg V2F5IHRvIF BpY2sgU3Rv Y2tzPC9iPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwhLS0KIC AgICAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nbWFy Z2luLXRvcD ogMTZweDsg Zm9udC1zaX plOiAxNHB4 OyBjb2xvcj ogIzQ0NDsg Zm9udC1mYW 1pbHk6IC1h cHBsZS1zeX N0ZW0sIEJs aW5rTWFjU3 lzdGVtRm9u dCwgU2Vnb2 UgVUksIFJv Ym90bywgSG VsdmV0aWNh IE5ldWUsIH NhbnMtc2Vy aWY7IGxpbm UtaGVpZ2h0 OiAxLjY7Jz 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIE hhdmUgeW91 IGhlYXJkIG Fib3V0IG91 ciBzaG9ydC A8c3Ryb25n IHN0eWxlPS dmb250LXdl aWdodDogNj AwOyc+RGFp bHkgVmlkZW 8gTmV3c2xl dHRlcjwvc3 Ryb25nPj8K ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxh IGhyZWY9J2 h0dHBzOi8v d3d3Lmluc2 lnaHRmdWx2 YWx1ZS5jb2 0vbmV3c2xl dHRlci5waH AnIHRhcmdl dD0nX2JsYW 5rJyBzdHls ZT0nY29sb3 I6ICMwMDdC RkY7IHRleH QtZGVjb3Jh dGlvbjogbm 9uZTsgZm9u dC13ZWlnaH Q6IDUwMDsg bWFyZ2luLW xlZnQ6IDZw eDsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIE ZpbmQgb3V0 IG1vcmUKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9kaX Y+CiAgICAg ICAgICAgIC AgICAgICAg ICAgIC0tPg ogICAgICAg ICAgICAgIC AgICAgIDwv ZGl2PgogIC AgICAgICAg ICAgICAgPC 9kaXY+CiAg ICAgICAgIC AgIDwvZGl2 PgogICAgIC AgICAgICAK ICAgICAgIC AKICAgICAg ICA8c3Bhbi BjbGFzcz0n Ymx1cnJlZC 10ZXh0Jz4K ICAgICAgIC AgICAgVjJW emRDQlFhRy BGeWJXRmpa WFYwIGFXTm hiQ0JUWlgg SjJhV05sY3 lCcCBjeUJo SUhkbGJHIH d0YTI1dmQy NGcgWTI5dG NHRnVlUyBC cGJpQjBhR1 VnIGNHaGhj bTFoWTIgVj FkR2xqWVd3 ZyBZVzVrSU dKcGIzIFJs WTJodWIyeH YgWjNrZ2My VmpkRyA5eW N5d2djSEpw IGJXRnlhV3 g1SUcgWnZZ M1Z6YVc1bi BJRzl1SUhS b1pTIEJrWl hOcFoyNGcg WVc1a0lHMW hibiBWbVlX TjBkWEpwIG JtY2diMlln Y0cgRmphMk ZuYVc1biBJ R0Z1WkNCa1 pXIHhwZG1W eWVTQnogZV hOMFpXMXpJ RyBadmNpQn BibXBsIFkz UmhZbXhsSU cgUnlkV2R6 TGlCSSBaWE psSUdGeVpT IEJ6YjIxbE lHbHUgZEdW eVpYTjBhVy A1bklHWmhZ M1J6IElHRm liM1YwSUgg Um9aU0JqYj IxdyBZVzU1 T2p4aWNqID R4TGlBOGMz UnkgYjI1bl BraHBjMyBS dmNuazhMM0 4wIGNtOXVa ejQ2SUYgZG xjM1FnVUdo aCBjbTFoWT JWMWRHIGxq WVd3Z1UyVn kgZG1salpY TWdkMiBGek lHWnZkVzVr IFpXUWdhVz RnTVQga3lN eUJpZVNCaC BJSEJvWVhK dFlXIE5wYz NRZ2JtRnQg WldRZ1YybH NiRyBsaGJT QklMaUJYIF pYTjBMaUJV YUcgVWdZMj l0Y0dGdSBl U0J6ZEdGeW RHIFZrSUhk cGRHZ2cgZE dobElIQnli MiBSMVkzUn BiMjRnIGIy WWdjblZpWW 0gVnlJR052 YlhCdiBibV Z1ZEhNZ1pt IDl5SUhSb1 pTQncgYUdG eWJXRmpaWC BWMGFXTmhi Q0JwIGJtUj FjM1J5ZVMg NDhZbkkrTW k0ZyBQSE4w Y205dVp6ID VKYm01dmRt RjAgYVhabE lGQnliMiBS MVkzUnpQQz l6IGRISnZi bWMrT2kgQl haWE4wSUds eiBJSEpsWT I5bmJtIGw2 WldRZ1ptOX kgSUdSbGRt VnNiMyBCcG JtY2dkR2hs IElHWnBjbk 4wSUggTmxi R1l0YzJWaC BiR2x1WnlC eWRXIEppWl hJZ2MzUnYg Y0hCbGNpd2 dkMiBocFky Z2djbVYyIG IyeDFkR2x2 Ym0gbDZaV1 FnYUc5MyBJ RzFsWkdsal lYIFJwYjI1 eklHRnkgWl NCemRHOXla VyBRZ1lXNW tJR1JwIGMz Qmxibk5sWk MgNGdWR2hw Y3lCcCBibT V2ZG1GMGFX IDl1SUhCeW IzWnAgWkdW a0lHSmxkSC BSbGNpQnpk R1Z5IGFXeH BkSGtnWVcg NWtJR0ZqWT JWeiBjMmxp YVd4cGRIIG tnWm05eUlH bHUgYW1Wam RHRmliRyBV Z1pISjFaM0 11IFBHSnlQ ak11SUQgeH pkSEp2Ym1j KyBSMnh2WW 1Gc0lGIEps WVdOb1BDOX ogZEhKdmJt YytPaSBCWF pYTjBJRzl3 IFpYSmhkR1 Z6SUcgbHVJ RzExYkhScC BjR3hsSUdO dmRXIDUwY2 1sbGN5Qmgg Y205MWJtUW dkRyBobElI ZHZjbXhrIE xDQndjbTky YVcgUnBibW NnYzJWeSBk bWxqWlhNZ2 RHIDhnWVNC a2FYWmwgY2 5ObElISmhi bSBkbElHOW 1JR05zIGFX VnVkSE1nYV cgNGdkR2hs SUhCbyBZWE p0WVdObGRY IFJwWTJGc0 lHRnUgWkNC aWFXOTBaVy BOb2JtOXNi MmQ1IElHbH VaSFZ6ZEgg SnBaWE11SU ZSbyBaV2x5 SUdkc2IyIE poYkNCd2Nt VnogWlc1al pTQmxibSBG aWJHVnpJSF JvIFpXMGdk RzhnYlcgVm xkQ0IyWVhK NSBhVzVuSU hKbFozIFZz WVhSdmNua2 cgY21WeGRX bHlaVyAxbG JuUnpJR0Z1 IFpDQmpkWE 4wYjIgMWxj aUJ1WldWay BjeTQ4WW5J K05DIDRnUE hOMGNtOXUg Wno1VGRYTj BZVyBsdVlX SnBiR2wwIG VTQkpibWww YVcgRjBhWF psY3p3diBj M1J5YjI1bl BqIG9nVkdo bElHTnYgYl hCaGJua2dh RyBGeklHMW haR1VnIFky OXRiV2wwYl cgVnVkSE1n ZEc4ZyBjM1 Z6ZEdGcGJt IEZpYVd4cG RIa2cgWVc1 a0lHRnBiWC BNZ2RHOGdj bVZrIGRXTm xJR2wwY3kg QmxiblpwY2 05dSBiV1Z1 ZEdGc0lHIG x0Y0dGamRD QjAgYUhKdm RXZG9JSCBa aGNtbHZkWE 1nIGFXNXBk R2xoZEcgbD JaWE1zSUds dSBZMngxWk dsdVp5IEIz WVhOMFpTQn kgWldSMVkz UnBiMiA0Z1 lXNWtJR1Z1 IFpYSm5lU0 JsWm0gWnBZ MmxsYm1ONS BJSEJ5YjJk eVlXIDF6TG p4aWNqNDEg TGlBOGMzUn liMiA1blBs QmhjblJ1IF pYSnphR2x3 Y3kgQjNhWF JvSUVKcCBi M1JsWTJnZ1 EyIDl0Y0dG dWFXVnogUE M5emRISnZi bSBjK09pQl haWE4wIElH TnZiR3hoWW 0gOXlZWFJs Y3lCMyBhWF JvSUcxaGJu IGtnWW1sdm RHVmogYUNC bWFYSnRjeS BCMGJ5Qmta WFpsIGJHOX dJR04xYzMg UnZiV2w2Wl dRZyBaSEox WnlCa1pXIH hwZG1WeWVT QnogZVhOMF pXMXpJRyBG dVpDQndZV0 5yIFlXZHBi bWNnYzIgOX NkWFJwYjI1 eiBMQ0J3WV hKMGFXIE4x YkdGeWJIa2 cgWm05eUlH TnZiWCBCc1 pYZ2dZbWx2 IGJHOW5hV0 56SUcgRnVa Q0J6Y0dWai BhV0ZzZEhr Z2NHIGhoY2 0xaFkyVjEg ZEdsallXeH pMaiB4aWNq NDJMaUE4IG MzUnliMjVu UGsgbHVkbV Z6ZEcxbCBi blFnYVc0Z1 VpIFpoYlhB N1JEd3YgYz NSeWIyNW5Q aiBvZ1ZHaG xJR052IGJY QmhibmtnYV cgNTJaWE4w Y3lCeiBhV2 R1YVdacFky IEZ1ZEd4NU lHbHUgSUhK bGMyVmhjbS BOb0lHRnVa Q0JrIFpYWm xiRzl3Ylcg VnVkQ0IwYn lCcCBibTV2 ZG1GMFpTIE JoYm1RZ2FX MXcgY205Ml pTQnBkSCBN Z2NISnZaSF ZqIGRDQnZa bVpsY20gbH VaM01zSUdW dSBjM1Z5YV c1bklIIFJv WlhrZ2NtVn QgWVdsdUlH RjBJSCBSb1 pTQm1iM0ps IFpuSnZibl FnYjIgWWdk R2hsSUdsdS BaSFZ6ZEhK NUxqIHhpY2 o0M0xpQTgg YzNSeWIyNW 5QbCBGMVlX eHBkSGtnIF FYTnpkWEpo Ym0gTmxQQz l6ZEhKdiBi bWMrT2lCWF pYIE4wSUhC c1lXTmwgY3 lCaElITjBj bSA5dVp5Qm xiWEJvIFlY TnBjeUJ2Ym kgQnhkV0Zz YVhSNSBJR0 52Ym5SeWIy IHdnWVc1a0 lISmwgWjNW c1lYUnZjbi BrZ1kyOXRj R3hwIFlXNW paU3dnZDIg aHBZMmdnYV hNZyBZM0ox WTJsaGJDIE JuYVhabGJp QjAgYUdVZ1 kzSnBkRyBs allXd2dibU YwIGRYSmxJ RzltSUggUm 9aV2x5SUhC eSBiMlIxWT NSeklHIGx1 SUhCMVlteH AgWXlCb1pX RnNkRyBnZ1 lXNWtJSE5o IFptVjBlUz Q4WW4gSStP QzRnUEhOMC BjbTl1Wno1 VGRHIDlqYX lCTWFYTjAg YVc1blBDOX pkSCBKdmJt YytPaUJYIF pYTjBJRkJv WVggSnRZV0 5sZFhScCBZ MkZzSUZObG NuIFpwWTJW eklHbHogSU hCMVlteHBZ MiB4NUlIUn lZV1JsIFpD QnZiaUIwYU cgVWdUbVYz SUZsdiBjbX NnVTNSdlky IHNnUlhoam FHRnUgWjJV Z2RXNWtaWC BJZ2RHaGxJ SFJwIFkydG xjaUJ6ZVcg MWliMndnVj FOVSBManhp Y2o0NUxpIE E4YzNSeWIy NW4gUGtOdm JXMTFibSBs MGVTQkZibW RoIFoyVnRa VzUwUEMgOX pkSEp2Ym1j KyBPaUJVYU dVZ1kyIDl0 Y0dGdWVTQn AgY3lCcGJu WnZiSCBabF pDQnBiaUIy IFlYSnBiM1 Z6SUcgTnZi VzExYm1sMC BlU0JwYm1s MGFXIEYwYV habGN5Qmgg Ym1RZ2NHaH BiRyBGdWRH aHliM0JwIF l5QmxabVp2 Y24gUnpMQ0 JwYm1OcyBk V1JwYm1jZ2 MzIFZ3Y0c5 eWRHbHUgWn lCbFpIVmpZ WCBScGIyNW hiQ0J3IGNt OW5jbUZ0Y3 kgQmhibVFn YUdWaCBiSF JvWTJGeVpT IEJoWTJObG MzTXUgUEdK eVBqRXdMaS BBOGMzUnli MjVuIFBrbH VaSFZ6ZEgg SjVJRkpsWT I5biBibWww YVc5dVBDID l6ZEhKdmJt YysgT2lCWF pYTjBJRyBo aGN5QnlaV0 5sIGFYWmxa Q0J1ZFcgMW xjbTkxY3lC aCBkMkZ5Wk hNZ1lXIDVr SUhKbFkyOW 4gYm1sMGFX OXVJRyBadm NpQnBkSE1n IFkyOXVkSE pwWW4gVjBh Vzl1Y3lCMC BieUIwYUdV Z2NHIGhoY2 0xaFkyVjEg ZEdsallXd2 dhVyA1a2RY TjBjbmtzIE lIQmhjblJw WTMgVnNZWE pzZVNCcCBi aUJoY21WaG N5IEJ6ZFdO b0lHRnogSU hCeWIyUjFZ MyBRZ2FXNX ViM1poIGRH bHZiaUJoYm 0gUWdZMjl5 Y0c5eSBZWF JsSUhOdlky IGxoYkNCeV pYTncgYjI1 emFXSnBiRy BsMGVTNGdQ R0p5IFBsUm 9aWE5sSUcg WmhZM1J6SU docCBaMmhz YVdkb2RDIE JYWlhOMElG Qm8gWVhKdF lXTmxkWCBS cFkyRnNJRk 5sIGNuWnBZ MlZ6NG8gQ1 pJSE5wWjI1 cCBabWxqWV c1MElIIEp2 YkdVZ2FXNG cgZEdobElI Qm9ZWCBKdF lXTmxkWFJw IFkyRnNJR2 x1WkggVnpk SEo1SUdGdS BaQ0JwZEhN Z1kyIDl0Yl dsMGJXVnUg ZENCMGJ5Qn BibSA1dmRt RjBhVzl1IE lHRnVaQ0J6 ZFggTjBZV2 x1WVdKcCBi R2wwZVM0OF luIEkrCiAg ICAgICAgPC 9zcGFuPgog ICAgICAgIA ogICAgICAg IA==